tiprankstipranks
Trending News
More News >
Cormedix (CRMD)
NASDAQ:CRMD
US Market
Advertisement

Cormedix (CRMD) Technical Analysis

Compare
1,396 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Cormedix’s (CRMD) Moving Averages Convergence Divergence (MACD) indicator is 0.58, suggesting Cormedix is a Sell.
Cormedix’s (CRMD) 20-Day exponential moving average is 12.81, while Cormedix’s (CRMD) share price is $14.14, making it a Buy.
Cormedix’s (CRMD) 50-Day exponential moving average is 12.30, while Cormedix’s (CRMD) share price is $14.14, making it a Buy.

Cormedix (CRMD) Pivot Points

Aug 28, 2025, 07:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.36
13.51
13.75
13.90
14.14
14.29
14.53
Fibonacci
13.51
13.66
13.75
13.90
14.05
14.14
14.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cormedix (CRMD) Moving Averages

Aug 28, 2025, 07:14 PM
Period
Simple
Exponential
MA5
13.82Buy
13.81Buy
MA10
13.43Buy
13.37Buy
MA20
12.44Buy
12.81Buy
MA50
12.33Buy
12.30Buy
MA100
11.54Buy
11.75Buy
MA200
10.75Buy
10.83Buy
Cormedix’s (CRMD) 10-Day exponential moving average is 13.37, while Cormedix’s (CRMD) share price is $14.14, making it a Buy.
Cormedix’s (CRMD) 100-Day exponential moving average is 11.75, while Cormedix’s (CRMD) share price is $14.14, making it a Buy.
Cormedix’s (CRMD) stock price is $14.14 and Cormedix’s (CRMD) 50-day simple moving average is 12.33, creating a Buy signal.
Cormedix’s (CRMD) stock price is $14.14 and Cormedix’s (CRMD) 100-day simple moving average is 11.54, creating a Buy signal.
Cormedix’s (CRMD) stock price is $14.14 and Cormedix’s (CRMD) 200-day simple moving average is 10.75, creating a Buy signal.

Cormedix (CRMD) Technical Indicators

Aug 28, 2025, 07:14 PM
Name
Value
Implied Action
RSI (14)
68.70
Neutral
STOCH (9,6)
80.67
Sell
STOCHRSI (14)
89.84
Sell
MACD (12,26)
0.58
Sell
ADX (14)
24.63
Neutral
Williams %R
-6.49
Sell
CCI (14)
111.18
Sell
ATR (14)
0.70
-
Ultimate Oscillator
51.50
Neutral
ROC
30.80
Buy
Cormedix’s (CRMD) Relative Strength Index (RSI) is 68.70, creating a Neutral signal.
Cormedix’s (CRMD) Trend Strength Indicator (ADX) is 24.63, creating a Neutral signal.
Cormedix’s (CRMD) Commodity Channel Index (CCI) is 111.18, creating a Sell signal.
Cormedix’s (CRMD) Price Rate of Change (ROC) is 30.80, creating a Buy signal.

FAQ

Is CRMD a Buy, Hold, or Sell?
Based on CRMD’s technical indicators, CRMD is a Buy.
    What is CRMD’s RSI (14)?
    CRMD’s RSI (14) is 68.70, which suggests CRMD is a Neutral.
      What is CRMD’s MACD?
      CRMD’s MACD is 0.58, which suggests CRMD is a Sell.
        What is CRMD’s 5-day moving average?
        CRMD’s 5-day moving average is 13.82, which suggests CRMD is a Buy.
          What is CRMD’s 20-day moving average?
          CRMD 20-day moving average is 12.44, which suggests CRMD is a Buy.
            What is CRMD’s 50-day moving average?
            CRMD’s 50-day moving average is 12.33, which suggests CRMD is a Buy.
              What is CRMD’s 200-day moving average?
              CRMD’s 200-day moving average is 10.75, which suggests CRMD is a Buy.
                What is CRMD’s Williams % R (14)?
                CRMD’s Williams % R (14) is -6.49, which suggests CRMD is a Sell.
                  What is CRMD’s CCI (14)?
                  CRMD’s CCI (14) is 111.18, which suggests CRMD is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis